REFERENCES
- Bent S, et al. Spontaneous bleeding associated with ginkgo biloba: a case report and systematic review of the literature. J Gen Intern Med 2005; 20(7)657–661, [INFOTRIEVE]
- Almeida JC, Grimsley EW. Coma from the health food store: interaction between kava and alprazolam. Ann Intern Med 1996; 125(11)940–941, [INFOTRIEVE]
- Barone GW, et al. Drug interaction between St. John’s Wort and cyclosporine. Ann Pharmacother 2000; 34(9)1013–1016, [INFOTRIEVE], [CROSSREF]
- Coon JT, Ernst E. Panax ginseng: a systematic review of adverse effects and drug interactions. Drug Saf 2002; 25(5)323–344, [INFOTRIEVE], [CROSSREF]
- Cupp MJ. Herbal remedies: adverse effects and drug interactions. Am Fam Physician 1999; 59(5)1239–1245, [INFOTRIEVE]
- Fessenden JM, Wittenborn W, Clarke L. Gingko biloba: a case report of herbal medicine and bleeding postoperatively from a laparoscopic cholecystectomy. Am Surg 2001; 67(1)33–35, [INFOTRIEVE]
- Fugh-Berman A. Herb-drug interactions. Lancet 2000; 355(9198)134–138, [INFOTRIEVE], [CROSSREF]
- Hu Z, et al. Herb-drug interactions: a literature review. Drugs 2005; 65(9)1239–1282, [INFOTRIEVE], [CROSSREF]
- Izzo AA, Ernst E. Interactions between herbal medicines and prescribed drugs: a systematic review. Drugs 2001; 61(15)2163–2175, [INFOTRIEVE], [CROSSREF]
- Izzo AA. Drug interactions with St. John’s Wort (Hypericum perforatum): a review of the clinical evidence. Int J Clin Pharmacol Ther 2004; 42(3)139–148, [INFOTRIEVE]
- Moschella C, Jaber BL. Interaction between cyclosporine and Hypericum perforatum (St. John’s Wort) after organ transplantation. Am J Kidney Dis 2001; 38(5)1105–1107, [INFOTRIEVE]
- Smolinske SC. Dietary supplement-drug interactions. J Am Med Womens Assoc 1999; 54(4)191–192, 195 [INFOTRIEVE]
- Vaes LP, Chyka PA. Interactions of warfarin with garlic, ginger, ginkgo, or ginseng: nature of the evidence. Ann Pharmacother 2000; 34(12)1478–1482, [INFOTRIEVE], [CROSSREF]
- Fugh-Berman A, Ernst E. Herb-drug interactions: review and assessment of report reliability. Br J Clin Pharmacol 2001; 52(5)587–595, [INFOTRIEVE], [CROSSREF]
- Durr D, Stieger B, Kullak-Ublick GA, Rentsch KM, Steinart HC, Meier PJ, Fattinger K. St John’s Wort induces intestinal P-glycoprotein/MDR1 and intestinal and hepatic CYP3A4. Clin Pharmacol Ther 2000; 68(6)598–604, [INFOTRIEVE], [CROSSREF]
- Mueller SC, Majcher-Peszynska J, Uehleke B, Klammt S, Mundkowski RG, Miekisch W, Sievers H, Bauer S, Frank B, Kundt G, Drewelow B. The extent of induction of CYP3A by St. John’s Wort varies among products and is linked to hyperforin dose. Eur J Clin Pharmacol 2006; 62(1)29–36, [INFOTRIEVE], [CROSSREF]
- Wang Z, Gorski JC, Hamman MA, Huang SM, Lesko LJ, Hall SD. The effects of St John’s Wort (Hypericum perforatum) on human cytochrome P450 activity. Clin Pharmacol Ther 2001; 70(4)317–326, [INFOTRIEVE], [CROSSREF]
- Russmann S, Lauterberg BH, Barguil Y, Choblet E, Cabalion P, Rentsch K, Wenk M. Traditional aqueous kava extracts inhibit cytochrome P450 1A2 in humans: protective effect against environmental carcinogens?. Clin Pharmacol Ther 2005; 77(5)453–454, [INFOTRIEVE], [CROSSREF]
- Mathews JM, Etheridge AS, Black SR. Inhibition of human cytochrome P450 activities by kava extract and kavalactones. Drug Metab Dispos 2002; 30(11)1153–1157, [INFOTRIEVE], [CROSSREF]
- Gurley BJ, Gardner SF, Hubbard MA, Williams DK, Gentry WB, Khan IA, Shah A. In vivo effects of goldenseal, kava kava, black cohosh, and valerian on human cytochrome P450 1A2, 2D6, 2E1, and 3A4/5 phenotypes. Clin Pharmacol Ther 2005; 77(5)415–426, [INFOTRIEVE], [CROSSREF]
- Brady JF, Ishizaki H, Fukuto JM, Lin MC, Fadel A, Gapac JM, Yang CS. Inhibition of cytochrome P-450 2E1 by diallyl sulfide and its metabolites. Chem Res Toxicol 1991; 4(6)642–647, [INFOTRIEVE], [CROSSREF]
- Tsukamoto S, Aburatani M, Ohta T. Isolation of CYP3A4 Inhibitors from the Black Cohosh (Cimicifuga racemosa). Evid Based Complement Alternat Med 2005; 2(2)223–226, [INFOTRIEVE], [CROSSREF]
- Gurley BJ, Barone GW, Williams DK, Carrier J, Breen P, Yates CR, Song PF, Hubbard MA, Tong Y, Cheboyina S. Effect of milk thistle (Silybum marianum) and black cohosh (Cimicifuga racemosa) supplementation on digoxin pharmacokinetics in humans. Drug Metab Dispos 2006; 34(1)69–74, [INFOTRIEVE], [CROSSREF]
- Donovan JL, DeVane CL, Chavin KD, Wang JS, Gibson BB, Gefroh HA, Markowitz JS. Multiple night-time doses of valerian (Valeriana officinalis) had minimal effects on CYP3A4 activity and no effect on CYP2D6 activity in healthy volunteers. Drug Metab Dispos 2004; 32(12)1333–1336, [INFOTRIEVE], [CROSSREF]
- Bal Dit Sollier C, Caplain H, Drouet L. No alteration in platelet function or coagulation induced by EGb761 in a controlled study. Clin Lab Haematol 2003; 25(4)251–253, [INFOTRIEVE], [CROSSREF]
- Kohler S, Funk P, Kieser M. Influence of a 7-day treatment with Ginkgo biloba special extract EGb 761 on bleeding time and coagulation: a randomized, placebo-controlled, double-blind study in healthy volunteers. Blood Coagul Fibrinolysis 2004; 15(4)303–309, [INFOTRIEVE], [CROSSREF]
- German K, Kumar U, Blackford HN. Garlic and the risk of TURP bleeding. Br J Urol 1995; 76(4)518, [INFOTRIEVE]
- Burnham BE. Garlic as a possible risk for postoperative bleeding. Plast Reconstr Surg 1995; 95(1)213, [INFOTRIEVE]
- Rose KD, et al. Spontaneous spinal epidural hematoma with associated platelet dysfunction from excessive garlic ingestion: a case report. Neurosurgery 1990; 26(5)880–882, [INFOTRIEVE], [CROSSREF]
- Corrigan JJ, Jr., Marcus FI. Coagulopathy associated with vitamin E ingestion. JAMA 1974; 230(9)1300–1301, [INFOTRIEVE], [CROSSREF]
- Page RL, II, Lawrence JD. Potentiation of warfarin by dong quai. Pharmacotherapy 1999; 19(7)870–876, [INFOTRIEVE], [CROSSREF]
- Heck AM, DeWitt BA, Lukes AL. Potential interactions between alternative therapies and warfarin. Am J Health Syst Pharm 2000; 57(13)1221–1227, quiz 1228–1230 [INFOTRIEVE]
- Haller CA, Benowitz NL, Jacob P, III. Hemodynamic effects of ephedra-free weight-loss supplements in humans. Am J Med 2005; 118(9)998–1003, [INFOTRIEVE], [CROSSREF]
- Jamieson DD, Duffield PH. Positive interaction of ethanol and kava resin in mice. Clin Exp Pharmacol Physiol 1990; 17(7)509–514, [INFOTRIEVE]
- Stevinson C, Huntley A, Ernst E. A systematic review of the safety of kava extract in the treatment of anxiety. Drug Saf 2002; 25(4)251–261, [INFOTRIEVE], [CROSSREF]
- Haller CA, et al. Concentrations of ephedra alkaloids and caffeine in commercial dietary supplements. J Anal Toxicol 2004; 28(3)145–151, [INFOTRIEVE]
- Green GA, Starcevic B. Analysis of over-the-counter dietary supplements. Clinical Journal of Sports Medicine 2001; 11: 254–259, [CROSSREF]
- Harkey MR, Henderson GL, Gershwin ME, Stern JS, Hackman RM. Variability in commercial ginseng products: an analysis of 25 preparations. Am J Clin Nutr 2001; 73: 1101–1106, [INFOTRIEVE]
- Russell ASHA, Jamali F. Active ingredient consistency of commercially available glucosamine sulfate products. J Rheumatol 2002; 29: 2407–2409, [INFOTRIEVE]
- Ko R. Adulterants in Asian Patent Medicines. New Engl J Med 1998; 339(12)847, [INFOTRIEVE], [CROSSREF]
- Ernst E. Adulteration of Chinese herbal medicines with synthetic drugs: a systematic review. J Internal Med 2002; 252: 107–113, [INFOTRIEVE], [CROSSREF]
- Ernst E. Risks of herbal medicinal products. Pharmacoepidemiology and Drug Safety 2004; 13: 767–771, [INFOTRIEVE], [CROSSREF]
- Philen RM, Hill RH, Jr., Flanders WD, Caudill SP, Needham L, Sewell L, Sampson EJ, Falk H, Kilbourne EM. Tryptophan contaminants associated with eosinophilia-myalgia syndrome. Am J Epidemiol 1993; 138: 154–159, [INFOTRIEVE]
- Yang CS, Chang SG, Hsu HC. Rapidly progressive fibrosing interstitial nephritis associated with Chinese herbal drugs. Am J Kidney Dise 2000; 35(2)313–318
- Haller CA, Anderson IB, Kim S, Blanc P. An evaluation of selected herbal reference texts and comparison to published reports of adverse herbal events. Adv Drug React Toxicol Rev 2002; 21(3)143–150